Our data have revealed that SCF+G-CSF treatment reduces diffuse and fibrillar Aβ deposits, increases the association of microglia/macrophages with senile plaques, and enhances Aβ uptake by microglia/macrophages in the brains of aged APP/PS1 mice. The gene discussed is KITLG; the disease is Senile plaques.